Lyell Wealth Management, LP Astrazeneca PLC Transaction History

Lyell Wealth Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$63.15 - $71.6 $31,575 - $35,800	-500 Reduced 10.62%	4,206 $291,000
Q2 2022 Jul 28, 2022	SELL	$59.26 - $71.14 $10,370 - $12,449	-175 Reduced 3.59%	4,706 $311,000
Q1 2022 May 04, 2022	BUY	$55.72 - $67.12 $271,969 - $327,612	4,881 New	4,881 $324,000
Q3 2021 Nov 10, 2021	SELL	$55.56 - $60.79 $196,182 - $214,649	-3,531 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$48.42 - $60.18 $170,971 - $212,495	3,531 New	3,531 $212,000

1,510

501M

5.59M

3.18M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Lyell Wealth Management, LP, based on Form 13F filings with the SEC.

Stay updated on Lyell Wealth Management, LP with notifications on news.